BNTC

Benitec Biopharma Inc.

3.72 USD

Last updated Dec 10, 08:24 UTC

Yesterday HIGH

$3.4

Yesterday LOW

$3.24

52w HIGH

$9.01

52w LOW

$1.86

EPS

-2.76

PE

-1.35

Next Earnings

Feb 12, 2024

Overview News Insider Transactions Government Trades

Benitec Biopharma Inc. stock is up 8.77% since 30 days ago. The next earnings date is Feb 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 44.44% of the previous 8 December’s closed higher than November.

Benitec Biopharma focuses on the development of novel genetic medicines. The company is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. BB-103 for the treatment of chronic hepatitis B virus infection.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

-

Website

benitec.com

Lisa Levin

Tue Jun 27, 2023

Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Benzinga Insights

Tue Jun 27, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights

Tue Jun 27, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Lisa Levin

Mon Jun 26, 2023

Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500, also fell, dropping, 0.11% to 4,343.41.
Benzinga Insights

Mon Jun 26, 2023

12 Health Care Stocks Moving In Monday's Intraday Session
Lisa Levin

Mon Jun 26, 2023

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.
Lisa Levin

Mon Jun 26, 2023

Crude Oil Rises; Carnival Shares Drop After Q2 Results

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 80 points on Monday. The Dow traded down 0.02% to 33,719.54 while the NASDAQ fell 0.53% to 13,420.67. The S&P 500, also fell, dropping, 0.19% to 4,340.11.
richadhand@benzinga.com

Mon Jun 26, 2023

JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $4 Price Target

JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $4 price target.
Henry Khederian

Mon Jun 26, 2023

What In The World Is Going On With Benetic Biopharma (BNTC) Stock

Benetic Biopharma Inc (NASDAQ: BNTC) shares are trading higher by 46.35% to $0.29 Monday morning after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy
Benzinga Insights

Mon Jun 26, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session

Smith Edward F, Director

Wed Dec 6, 2023

BNTC Recent Insider Trades and Stock Chart

35,000 shares awarded
Francis Peter, Director

Wed Dec 6, 2023

BNTC Recent Insider Trades and Stock Chart

35,000 shares awarded
BUCHI J KEVIN, Director

Wed Dec 6, 2023

BNTC Recent Insider Trades and Stock Chart

35,000 shares awarded